Demographic, risk factors, clinical, and microbiological characteristics of 15 cases of bacterial keratitis with “very poor outcome”
| Sex | Age | Local risk factor | Previous topical treatment | Surface of infiltrate (mm2) | Depth of stromal extension | AC inflammation (Tyndall effect) | Bacteria identified | Duration of hospitalisation | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| CL = contact lenses wear, AC = anterior chamber, PBK = pseudophakic bullous keratopathy, BCVA = best corrected visual acuity, CF = counting fingers. | |||||||||
| F | 27 | CL | Oxybuprocaïne, fusidic acid | 64 | >2/3 | Hypopyon 1 mm | Pseudomonas aeruginosa | 10 | Central corneal scarring, BCVA 20/200 |
| F | 89 | Exposure keratopathy | None | 16 | >2/3 | Hypopyon 1 mm | Pseudomonas aeruginosa | 12 | Permanent tarsorrhaphy |
| M | 25 | CL | None | 16 | >2/3 | + | Pseudomonas aeruginosa | 11 | Corneal scarring, BCVA 20/200 |
| M | 35 | Exposure keratopathy | Tobramycin | 9 | >2/3 | + | Streptococcus spp | 8 | Permanent tarsorrhaphy |
| M | 71 | Removal of corneal suture | None | 100 | >2/3 | Phtysis bulbi | Streptococcus sanguis | 20 | Evisceration |
| F | 7 | Corneal trauma | None | 16 | perforation | +++ | Streptococcus pneumoniae | 13 | Cyanoacrylate glue |
| M | 36 | PBK | Rifamycin, chloramphenicol | 4 | 1/3 | + | Streptococcus vestibularis | 11 | PK |
| M | 50 | Chronic ulcer of unknown aetiology | Dexamethasone, neomycin | 6 | perforation | +++ | None | 4 | Conjunctival flap |
| M | 86 | PBK | None | 9 | >2/3 | Phtysis bulbi | Staphylococcus aureus | 7 | Evisceration |
| F | 83 | Removal of corneal suture | None | 6 | >2/3 | Hypopyon 3 mm | Staphylococcus aureus | 15 | Corneal scarring, BCVA 20/200 |
| F | 50 | Blepharoplasty | Oxybuprocaïne, norfloxacine | 9 | >2/3 | ++ | None | 14 | Corneal scarring, BCVA CF |
| F | 27 | Exposure keratopathy | Norfloxacine, rifamycin | 4 | 1/3–2/3 | + | None | 3 | Permanent tarsorrhaphy |
| F | 45 | Exposure keratopathy | None | 3 | 1/3–2/3 | + | Staphylococcus epidermidis | 10 | Permanent tarsorrhaphy |
| M | 49 | Chronic ulcer of unknown aetiology | Tobramycin | 24 | >2/3 | ++ | Staphylococcus epidermidis | 60 | Conjunctival flap |
| M | 69 | Chronic ulcer of unknown aetiology | None | 9 | >2/3 | + | None | 19 | PK |